Deficiency of fat soluble vitamins after jejunoileal bypass surgery for obesity

Colon adenocarcinoma after jejunoileal bypass for morbid obesity

Jejunoileal bypass (JIB) was developed as a surgical treatment for morbid obesity in the early 1950s. However, this procedure is now known to be associated with multiple metabolic complications and has subsequently been abandoned as a viable bariatric procedure. Some of these known complications include renal stone formation, liver failure, migratory arthritis, fat-soluble deficiencies, blind-l...

Rectal hyperplasia after jejunoileal bypass for morbid obesity.

Jejunoileal bypass (JIB) has been widely used to treat patients with morbid obesity for the past 20 years. In rats JIB causes adaptive colonic hyperplasia and enhances colorectal neoplasia. In this study crypt cell production rate (CCPR) was measured stathmokinetically in cultured rectal biopsies from nine patients with JIB and seven controls without intestinal operations or disease. Crypt cell...

Jejunal villous atrophy with morbid obesity: death after jejunoileal bypass.

A 49-year-old woman with morbid obesity was found to have subtotal villous atrophy in an operative jejunal biopsy, taken when a jejunoileal bypass was created. After the operation, the patient developed marked weight loss, vomiting, hepatic failure, and a bizarre mental state with sudden losses of consciousness. Six months after the first operation the bypass was reversed but the patient develo...

Fat-soluble vitamins.

Jejunoileal bypass for obesity: a risk factor for tuberculosis.

D u r i n g the past 10 to 15 years, jejunoileal bypass operations have been used as a means of achieving weight loss in markedly obese individuals who are refractory to less drastic weight reduction measures. To date, at least 20 cases of tuberculosis following bypass operations have been rep0rted.l-l1 In those series which provided denominator data (ie, the total number of persons undergoing ...